Neuro Treatments
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
98
NCT01869933
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2013
Completion: Jun 30, 2013
NCT02735369
A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR
Phase: Phase 2
Start: Dec 31, 2014
Completion: Oct 31, 2016
NCT03630497
BN201 SAD MAD Study in Healthy Subjects
Start: May 27, 2018
Completion: Feb 22, 2019
Loading map...